Preventive Effects of a CVD Polypill on Developing Diabetes Among Patients With Metabolic Syndrome: Results of the PolyIran-Liver Trial
The polypill used in this study may have the potential to delay the onset of diabetes in patients with MetS more effectively than in the general population. However, its beneficial effects on the blood sugar levels of diabetic individuals require further investigation.
Authors
- Alireza Nateghi
- Masoud Khoshnia (ORCID: https://orcid.org/0000-0001-7352-8058)
- Hossein Poustchi (ORCID: https://orcid.org/0000-0003-4566-3628)
- Shahin Merat (ORCID: https://orcid.org/0000-0002-8088-6723)
- Abbas Mohagheghi (ORCID: https://orcid.org/0000-0002-8342-0400)
- Maryam Sharafkhah (ORCID: https://orcid.org/0000-0001-5466-488X)
- Elham Jafari (ORCID: https://orcid.org/0000-0002-8629-5852)
- Reza Malekzadeh (ORCID: https://orcid.org/0000-0002-9820-6335)
Institutions
- Golestan University (IR)
- Shariati Hospital (IR)
- Golestan University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Archives of Iranian Medicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.34172/aim.31839
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Research UK
- Tehran University of Medical Sciences and Health Services